Capital International Investors 13D/13G Filings for Rapport Therapeutics, Inc. Common Stock (RAPP)

Capital International Investors 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-13
12:26 pm
Purchase
2024-11-1413GRapport Therapeutics, Inc. Common Stock
RAPP
Capital International Investors2,602,529
7.100%
2,602,529increase
(New Position)
Filing